Literature DB >> 12084234

Androgen deficiency in the aging male: pathophysiology, diagnosis, and treatment alternatives.

V Flynn1, W J Hellstrom.   

Abstract

Androgen deficiency in the aging male is associated with negative effects on mood and cognition, diminished sexual function, and osteoporosis. The aging of our population, combined with an increased acceptance of medical technology, has focused greater attention on optimizing health during the "golden years." Androgen replacement therapy may remedy many of the deleterious consequences of hypogonadism. This communication reviews the clinical manifestations and diagnosis of androgen deficiency, the inherent risks and benefits of androgen replacement, and the options of testosterone replacement currently available.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12084234     DOI: 10.1007/s11934-001-0042-8

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  43 in total

1.  A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men.

Authors:  S Bhasin; R S Swerdloff; B Steiner; M A Peterson; T Meridores; M Galmirini; M R Pandian; R Goldberg; N Berman
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

Review 2.  Androgen and progestagen effects on plasma lipids.

Authors:  C J Bagatell; W J Bremner
Journal:  Prog Cardiovasc Dis       Date:  1995 Nov-Dec       Impact factor: 8.194

3.  Transdermal testosterone delivery: comparison between scrotal and nonscrotal delivery systems.

Authors:  S Lin; Q F Xing; Y W Chien
Journal:  Pharm Dev Technol       Date:  1999-08       Impact factor: 3.133

Review 4.  Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids.

Authors:  D Crook; M Seed
Journal:  Baillieres Clin Endocrinol Metab       Date:  1990-12

5.  Testosterone supplementation for erectile dysfunction: results of a meta-analysis.

Authors:  P Jain; A W Rademaker; K T McVary
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

Review 6.  Background for studies on the treatment of male osteoporosis: state of the art.

Authors:  J M Kaufman; O Johnell; E Abadie; S Adami; M Audran; B Avouac; W B Sedrine; G Calvo; J P Devogelaer; V Fuchs; G Kreutz; P Nilsson; H Pols; J Ringe; L Van Haelst; J Y Reginster
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

7.  Effects of testosterone replacement in hypogonadal men.

Authors:  P J Snyder; H Peachey; J A Berlin; P Hannoush; G Haddad; A Dlewati; J Santanna; L Loh; D A Lenrow; J H Holmes; S C Kapoor; L E Atkinson; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

8.  Validation of a screening questionnaire for androgen deficiency in aging males.

Authors:  J E Morley; E Charlton; P Patrick; F E Kaiser; P Cadeau; D McCready; H M Perry
Journal:  Metabolism       Date:  2000-09       Impact factor: 8.694

9.  Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.

Authors:  C Wang; A Iranmanesh; N Berman; V McDonald; B Steiner; F Ziel; S M Faulkner; R E Dudley; J D Veldhuis; R S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

Review 10.  Age-associated testosterone decline in men: clinical issues for psychiatry.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

View more
  1 in total

1.  Therapeutic androgen receptor ligands.

Authors:  George F Allan; Zhihua Sui
Journal:  Nucl Recept Signal       Date:  2003-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.